Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoît Froget

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
DNA Repair|April 7, 2007
Arrested replication fork processing: interplay between checkpoints and recombinationSarah Lambert, Benoît Froget, Antony M Carr
Molecular Biology of the Cell|November 23, 2007
Cleavage of stalled forks by fission yeast Mus81/Eme1 in absence of DNA replication checkpointBenoît Froget, Joël Blaisonneau, Sarah Lambert, et al.
American Journal of Hematology|April 18, 2009
Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximabFranck Assayag, Nicole Brousse, Jérôme Couturier, et al.
Anti-Cancer Drugs|October 14, 2009
Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenograftsFariba Némati, Catherine Daniel, Francisco Arvelo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
DNA Repair|April 7, 2007
Arrested replication fork processing: interplay between checkpoints and recombinationSarah Lambert, Benoît Froget, Antony M Carr
Molecular Biology of the Cell|November 23, 2007
Cleavage of stalled forks by fission yeast Mus81/Eme1 in absence of DNA replication checkpointBenoît Froget, Joël Blaisonneau, Sarah Lambert, et al.
American Journal of Hematology|April 18, 2009
Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximabFranck Assayag, Nicole Brousse, Jérôme Couturier, et al.
Anti-Cancer Drugs|October 14, 2009
Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenograftsFariba Némati, Catherine Daniel, Francisco Arvelo, et al.
Pageof 1